Literature DB >> 18495360

The role of active zone protein Rab3 interacting molecule 1 alpha in the regulation of norepinephrine release, response to novelty, and sleep.

G Lonart1, X Tang, F Simsek-Duran, M Machida, L D Sanford.   

Abstract

Sleep mechanisms and synaptic plasticity are thought to interact to regulate homeostasis and memory formation. However, the influences of molecules that mediate synaptic plasticity on sleep are not well understood. In this study we demonstrate that mice lacking Rab3 interacting molecule 1 alpha (RIM1 alpha) (Rim1 alpha KO), a protein of the synaptic active zone required for certain types of synaptic plasticity and learning, had 53+/-5% less baseline rapid eye movement (REM) sleep compared with their wild type littermates. Also, compared with wild type littermates, exposure of the mice to an open field or to a novel object induced more robust and longer lasting locomotion suggesting altered habituation. This difference in exploratory behavior correlated with genotype specific changes in REM and deregulated release of norepinephrine in the cortex and basal amygdala of the Rim1 alpha KO mice. Also, moderate sleep deprivation (4 h), a test of the homeostatic sleep response, induced REM sleep rebound with different time course in Rim1 alpha KO and their wild type littermates. As norepinephrine plays an important role in regulating arousal and REM sleep, our data suggest that noradrenergic deficiency in Rim1 alpha KO animals impacts exploratory behavior and sleep regulation and contributes to impairments in learning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18495360     DOI: 10.1016/j.neuroscience.2008.03.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Rim1 modulates direct G-protein regulation of Ca(v)2.2 channels.

Authors:  Norbert Weiss; Alejandro Sandoval; Shigeki Kyonaka; Ricardo Felix; Yasuo Mori; Michel De Waard
Journal:  Pflugers Arch       Date:  2011-02-18       Impact factor: 3.657

Review 2.  Mammalian sleep genetics.

Authors:  Jessica M Kelly; Matt T Bianchi
Journal:  Neurogenetics       Date:  2012-09-14       Impact factor: 2.660

Review 3.  The genetic and molecular regulation of sleep: from fruit flies to humans.

Authors:  Chiara Cirelli
Journal:  Nat Rev Neurosci       Date:  2009-08       Impact factor: 34.870

Review 4.  Sleep, brain development, and autism spectrum disorders: Insights from animal models.

Authors:  Taylor Wintler; Hannah Schoch; Marcos G Frank; Lucia Peixoto
Journal:  J Neurosci Res       Date:  2020-03-25       Impact factor: 4.164

Review 5.  Sleep Disorders in Children With Autism Spectrum Disorder: Insights From Animal Models, Especially Non-human Primate Model.

Authors:  Shufei Feng; Haoyu Huang; Na Wang; Yuanyuan Wei; Yun Liu; Dongdong Qin
Journal:  Front Behav Neurosci       Date:  2021-05-20       Impact factor: 3.558

6.  Quantitative phosphoproteomic analysis of the molecular substrates of sleep need.

Authors:  Zhiqiang Wang; Jing Ma; Chika Miyoshi; Yuxin Li; Makito Sato; Yukino Ogawa; Tingting Lou; Chengyuan Ma; Xue Gao; Chiyu Lee; Tomoyuki Fujiyama; Xiaojie Yang; Shuang Zhou; Noriko Hotta-Hirashima; Daniela Klewe-Nebenius; Aya Ikkyu; Miyo Kakizaki; Satomi Kanno; Liqin Cao; Satoru Takahashi; Junmin Peng; Yonghao Yu; Hiromasa Funato; Masashi Yanagisawa; Qinghua Liu
Journal:  Nature       Date:  2018-06-13       Impact factor: 69.504

7.  Experimental Malaria in Pregnancy Induces Neurocognitive Injury in Uninfected Offspring via a C5a-C5a Receptor Dependent Pathway.

Authors:  Chloë R McDonald; Lindsay S Cahill; Keith T Ho; Jimmy Yang; Hani Kim; Karlee L Silver; Peter A Ward; Howard T Mount; W Conrad Liles; John G Sled; Kevin C Kain
Journal:  PLoS Pathog       Date:  2015-09-24       Impact factor: 6.823

8.  ADAR-mediated RNA editing suppresses sleep by acting as a brake on glutamatergic synaptic plasticity.

Authors:  J E Robinson; J Paluch; D K Dickman; W J Joiner
Journal:  Nat Commun       Date:  2016-01-27       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.